NCT02883647View on ClinicalTrials.gov

Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Chronic Hepatitis b
Interventions
DRUG

Entecavir or Tenofovir

Patients in retreatment group receive nucleos(t)ide analogs therapy (Entecavir 0.5mg/d or Tenofovir 300mg/d) again

Trial Locations (1)

510630

RECRUITING

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER